Dorkenoo, Ameyo M.
Phillips, Anna E.
Klein, Luke
Lack, Fiali
Ataba, Essoham
Yakpa, Kossi
Tagba, Atna-Edi
Assoti, Bozi-Esso
Sossou, Efoe
Tchalim, Mawèké
Datagni, Gbati
Seim, Anders
Milord, Marie Denise
Kassankogno, Yao
Article History
Received: 12 January 2023
Accepted: 14 July 2023
First Online: 4 September 2023
Declarations
:
: Approval for this study was received from Togo MOH Bioethics Committee for Health Research of the Togo Ministry of Health (approval number: 037/2021/CBRS of the Ministry of Health of Togo). Written informed consent was obtained from the parent or guardian of each child enrolled in this study. A child assent form was developed for the participating children to read so that they could understand the procedures and objectives of the study. Additional permission was sought from national, regional and district administrative authorities in the regions concerned. The unique codes were assigned to each participant, which were used to identify them for the purposes of this study instead of their names. All study records were kept in a secure room by the principal investigator (PI). All children who tested positive were referred to the health center for treatment according to WHO recommendations.
: Not applicable.
: The authors declare they have no competing interests.